GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kainos Medicine Inc (XKRX:284620) » Definitions » Price-to-Owner-Earnings

Kainos Medicine (XKRX:284620) Price-to-Owner-Earnings : (As of Jun. 19, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Kainos Medicine Price-to-Owner-Earnings?

As of today (2024-06-19), Kainos Medicine's share price is ₩4675.00. Kainos Medicine does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Kainos Medicine's Price-to-Owner-Earnings or its related term are showing as below:


XKRX:284620's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 33.725
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-19), Kainos Medicine's share price is ₩4675.00. Kainos Medicine's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-515.00. Therefore, Kainos Medicine's PE Ratio for today is At Loss.

As of today (2024-06-19), Kainos Medicine's share price is ₩4675.00. Kainos Medicine's EPS without NRI for the trailing twelve months (TTM) ended in was ₩-515.18. Therefore, Kainos Medicine's PE Ratio without NRI for today is At Loss.

During the past 7 years, Kainos Medicine's highest PE Ratio without NRI was 4105.77. The lowest was 0.00. And the median was 0.00.


Kainos Medicine Price-to-Owner-Earnings Historical Data

The historical data trend for Kainos Medicine's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kainos Medicine Price-to-Owner-Earnings Chart

Kainos Medicine Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Kainos Medicine Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Kainos Medicine's Price-to-Owner-Earnings

For the Biotechnology subindustry, Kainos Medicine's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kainos Medicine's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kainos Medicine's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Kainos Medicine's Price-to-Owner-Earnings falls into.



Kainos Medicine Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Kainos Medicine's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=4675.00/-510.24
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kainos Medicine  (XKRX:284620) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Kainos Medicine Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Kainos Medicine's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Kainos Medicine (XKRX:284620) Business Description

Traded in Other Exchanges
N/A
Address
16, Daewangpangyo-ro 712 beon-gil, 4th Floor, Institut Pasteur Korea, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13488
Kainos Medicine Inc conducts research and develops medicines used to treat brain diseases, cancers, and infectious diseases.

Kainos Medicine (XKRX:284620) Headlines

No Headlines